financetom
Business
financetom
/
Business
/
Sensient Technologies Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sensient Technologies Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued
Feb 14, 2025 4:23 AM

07:14 AM EST, 02/14/2025 (MT Newswires) -- Sensient Technologies ( SXT ) reported Q4 adjusted earnings Friday of $0.65 per diluted share, up from $0.51 a year earlier.

An analyst polled by FactSet expected $0.64.

Revenue for the quarter ended Dec. 31 was $376.4 million, compared with $349.3 million a year earlier.

Two analysts surveyed by FactSet expected $377.6 million.

The company said it expects high single-digit to double-digit growth in 2025 adjusted diluted earnings.

The analysts surveyed by FactSet expect non-GAAP EPS of $3.39.

Sensient Technologies ( SXT ) also said it expects a mid-single-digit revenue growth during the year.

Two analysts polled by FactSet expect $1.61 billion in revenue.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections
Eli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections
Oct 24, 2025
Eli Lilly and Company ( LLY ) and Adverum Biotechnologies, Inc. ( ADVM ) on Friday announced that they have entered into a definitive agreement under which Lilly will acquire Adverum Biotechnologies ( ADVM ), including its lead product, Ixo-vec. Acquisition Terms and Contingent Value Rights (CVR) Under the merger terms, Eli Lilly ( LLY ) will launch a tender...
Grindr Gets Buyout Proposal of $18 Per Share; Shares Rise
Grindr Gets Buyout Proposal of $18 Per Share; Shares Rise
Oct 24, 2025
10:30 AM EDT, 10/24/2025 (MT Newswires) -- Grindr ( GRND ) has received a proposal from James Fu Bin Lu and George Raymond Zage III to buy all of the company's shares that they do not already own at $18 per share in a going-private deal, according to a regulatory filing Friday. Lu and Zage said in a letter to...
Molina Healthcare Sees Medicaid, Marketplace Trends Weighing on 2025 Results, Deutsche Bank Says
Molina Healthcare Sees Medicaid, Marketplace Trends Weighing on 2025 Results, Deutsche Bank Says
Oct 24, 2025
10:28 AM EDT, 10/24/2025 (MT Newswires) -- Molina Healthcare ( MOH ) expects downward trends for Medicaid and its Marketplace business to weigh on its 2025 results, with Medicaid margin to continue dropping through 2026, Deutsche Bank said in a Friday note. The company reported disappointing Q3 results, said the investment firm, as its adjusted earnings fell to $1.84 per...
Eli Lilly to Acquire Eye Gene Therapy Developer Adverum Biotechnologies
Eli Lilly to Acquire Eye Gene Therapy Developer Adverum Biotechnologies
Oct 24, 2025
11:14 AM EDT, 10/24/2025 (MT Newswires) -- Eli Lilly ( LLY ) has agreed to acquire Adverum Biotechnologies ( ADVM ) , which is developing a therapy to treat vision loss, in a deal worth up to $12.47 per share, the companies said in a joint statement Friday. Adverum's lead product candidate, Ixo-vec, is in a phase 3 trial for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved